Evommune, Inc. Common Stock (EVMN)

28.65
+1.52 (5.60%)
NYSE · Last Trade: Apr 9th, 6:04 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
1 Under‑the‑Radar Biotech to Buy for Potential 10X Growth in the Next Decadefool.com
Evommune has two autoimmune disorder treatments with blockbuster potential.
Via The Motley Fool · March 10, 2026
The trading volume of these stocks is deviating from the norm in today's session.chartmill.com
Via Chartmill · February 13, 2026
On Wednesday, there are stocks with unusual volume. Let's take a look.chartmill.com
Via Chartmill · February 11, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · February 10, 2026
Here are the top movers in Tuesday's session.chartmill.com
Via Chartmill · February 10, 2026
This Biotech Stock Nearly Doubled In Value Today Morning – What’s Driving Investor Optimism?stocktwits.com
Via Stocktwits · February 10, 2026
These stocks are gapping in today's sessionchartmill.com
Via Chartmill · February 10, 2026
Top movers in Tuesday's pre-market sessionchartmill.com
Via Chartmill · February 10, 2026
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026marketbeat.com
Via MarketBeat · January 19, 2026